Literature DB >> 3966198

Evidence of hyperinsulinaemia and hypoxaemia in the cord blood of neonates born to mothers with gestational diabetes.

C M Macfarlane, N Tsakalakos.   

Abstract

Increased cord blood C-peptide levels in neonates born to mothers with gestational diabetes (GD) were directly correlated with the increased relative birth weight ratio (BWR) of these neonates. In addition, the percentage oxygen saturation of the cord blood was inversely correlated with cord blood C-peptide levels and with the relative BWR. These correlations were absent in neonates delivered to normal mothers. The results indicate the presence of both hyperinsulinaemia and mild hypoxaemia in neonates of mothers with GD. In poorly controlled diabetic pregnancy this hypoxaemia may constitute an important fetal risk factor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3966198

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  Calcitonin gene-related peptide contributes to the umbilical haemodynamic defence response to acute hypoxaemia.

Authors:  A S Thakor; D A Giussani
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

2.  Early diagnosis of chronic fetal hypoxia in a diabetic pregnancy.

Authors:  R J Bradley; K H Nicolaides; J M Brudenell; S Campbell
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09

3.  The influence of maternal glucose metabolism on fetal growth, development and morbidity in 917 singleton pregnancies in nondiabetic women.

Authors:  G Farmer; G Russell; D R Hamilton-Nicol; H O Ogenbede; I S Ross; D W Pearson; H Thom; D F Kerridge; H W Sutherland
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

Review 4.  The highs and lows of programmed cardiovascular disease by developmental hypoxia: studies in the chicken embryo.

Authors:  N Itani; C E Salinas; M Villena; K L Skeffington; C Beck; E Villamor; C E Blanco; D A Giussani
Journal:  J Physiol       Date:  2017-11-15       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.